Redescription of Babesia equi Laveran, 1901 as Theileria equi Mehlhorn, Schein 1998.
The horse-parasitizing species Babesia equi Laveran, 1901 was redescribed as Theileria equi Mehlhorn, Schein 1998 and, thus, transferred from one valid genus to another. This transfer was needed since it turned out that this horse parasite showed the relevant characteristics of theilerians with regard to biological data, morphological features, biochemical properties, and molecular biological relationships.
Mehlhorn
H
H
Institute of Zoology and Parasitology, Heinrich-Heine-University Düsseldorf, Germany.
Schein
E
E
D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D001096:Arachnid Vectors / Q000469:parasitology; D001403:Babesia / Q000145:classification* / Q000166:cytology / Q000254:growth & development; D004912:Erythrocytes / Q000469:parasitology; D006734:Horse Diseases / Q000188:drug therapy / Q000469:parasitology; D006736:Horses / Q000469:parasitology; D008018:Life Cycle Stages; D008214:Lymphocytes / Q000469:parasitology; D009285:Naphthoquinones / Q000627:therapeutic use; D010880:Piperidines; D011799:Quinazolines / Q000627:therapeutic use; D052999:Quinazolinones; D016794:Theileria / Q000145:classification* / Q000166:cytology / Q000254:growth & development; D013801:Theileriasis / Q000188:drug therapy / Q000469:parasitology; D013987:Ticks / Q000469:parasitology
D000981:Antiprotozoal Agents; D009285:Naphthoquinones; D010880:Piperidines; D011799:Quinazolines; D052999:Quinazolinones; C028032:parvaquone; C010176:halofuginone